CD4 and tuberculosis: In contrast our participants were established in HIV care, and we were evaluating the usefulness of LF-LAM as part of a routine screening algorithm for intensified TB case finding in HIV clinic attendees, although restricted to those with CD4 counts below 200x106/l for whom LF-LAM was most likely to be useful.